The $5 Billion Scrub: Europe Reinvents Hospital Hygiene

Europe’s hospitals spend $5 billion on automation to stop four million annual infections, as tech giants consolidate the sterilization market

20 Apr 2026

The European medical sterilisation market is projected to reach $5.23bn in 2026, driven by a regional push to modernise healthcare infrastructure. This capital transition follows rising pressure to address healthcare-associated infections, which affect approximately 4m patients across the continent annually. Germany and the UK have emerged as the primary markets for this equipment, as providers move away from legacy hardware in favour of automated and robotic-assisted systems.

Corporate activity in the sector has accelerated as manufacturers position themselves for these long-term procurement cycles. STERIS, a major industry player, recently completed an acquisition of surgical instrumentation and sterilisation assets from BD. The deal is intended to integrate hospital workflows, allowing for more streamlined management of medical tools.

While traditional steam-based systems remain the industry standard, demand is shifting toward low-temperature alternatives. Hydrogen peroxide plasma technology is seeing high growth rates due to its ability to process heat-sensitive instruments. These specialised systems are increasingly necessary as hospitals adopt sophisticated robotic surgical platforms that cannot withstand high heat.

The transition also reflects broader institutional goals regarding environmental sustainability. Modern units are being designed to lower water and chemical usage, assisting hospitals in meeting tighter regional green standards. Digital integration is a secondary driver; the inclusion of sensors and predictive analytics allows for real-time monitoring. This data provides an audit trail for regulators and helps facilities avoid unscheduled equipment failure.

However, institutional barriers remain. The European Medicines Agency indicates that complex certification processes can delay the adoption of new technology by up to 10% annually. Furthermore, the rising cost of imported electronic components is squeezing procurement budgets.

Despite these logistical pressures, the trend toward high-tech disinfection is expected to persist. Policy focus on patient safety and the operational efficiency of national health systems continues to underpin the market’s expansion. As infection control becomes a central pillar of hospital management, the shift toward sustainable, data-driven sterilisation is likely to define the sector’s landscape through the end of the decade.